Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 742099

How pharmacoeconomics should be applied to support decisions in lower income European countries?


Kalo, Zoltan; Vitezić, Dinko
How pharmacoeconomics should be applied to support decisions in lower income European countries? // Abstract Book, First Macedonian and Fourth Adriatic Congress on Pharmacoeconomics and Outcomes Research / Suturkova, Ljubica ; Vitezić, Dinko (ur.).
Ohrid, Sjeverna Makedonija, 2014. str. 11-11 (pozvano predavanje, međunarodna recenzija, sažetak, stručni)


CROSBI ID: 742099 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
How pharmacoeconomics should be applied to support decisions in lower income European countries?

Autori
Kalo, Zoltan ; Vitezić, Dinko

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
Abstract Book, First Macedonian and Fourth Adriatic Congress on Pharmacoeconomics and Outcomes Research / Suturkova, Ljubica ; Vitezić, Dinko - , 2014, 11-11

Skup
First Macedonian and Fourth Adriatic Congress on Pharmacoeconomics and Outcomes Research

Mjesto i datum
Ohrid, Sjeverna Makedonija, 24.04.2014. - 27.04.2014

Vrsta sudjelovanja
Pozvano predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
health care resources; reimbursement; new medicines; cost-effectiveness; pharmacoeconomic analyses

Sažetak
As health care resources are limited all over the world, reimbursement and formulary listing of new medicines is subject to their cost-effectiveness and affordability in more and more countries. The need for pharmacoeconomic evidence fundamentally changes the algorithm of coverage decisions, therefore medical professionals and policymakers have to be familiar with the principles of pharmacoeconomics, including advantages and limitations of different approaches to estimate the health benefit, cost-effectiveness and budget impact of medicines and the transferability of results among countries. Synthesis of scientific evidence provides better understanding of stakeholders on the real value of innovative medical technologies. The value proposition of health technologies are illustrated by different case studies in the workshop. In lower income European countries the major bottleneck of implementation evidence based health policy are the lack of trained health economists and local data for the adaptation of international economic models. The workshop provides practical guidance for the collection of local data in pharmacoeconomic analyses.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
062-0620063-0060 - Uporaba kardiovaskularnih lijekova i značaj farmakoekonomskih procjena (Vitezić, Dinko, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka

Profili:

Avatar Url Dinko Vitezić (autor)


Citiraj ovu publikaciju:

Kalo, Zoltan; Vitezić, Dinko
How pharmacoeconomics should be applied to support decisions in lower income European countries? // Abstract Book, First Macedonian and Fourth Adriatic Congress on Pharmacoeconomics and Outcomes Research / Suturkova, Ljubica ; Vitezić, Dinko (ur.).
Ohrid, Sjeverna Makedonija, 2014. str. 11-11 (pozvano predavanje, međunarodna recenzija, sažetak, stručni)
Kalo, Z. & Vitezić, D. (2014) How pharmacoeconomics should be applied to support decisions in lower income European countries?. U: Suturkova, L. & Vitezić, D. (ur.)Abstract Book, First Macedonian and Fourth Adriatic Congress on Pharmacoeconomics and Outcomes Research.
@article{article, author = {Kalo, Zoltan and Vitezi\'{c}, Dinko}, year = {2014}, pages = {11-11}, keywords = {health care resources, reimbursement, new medicines, cost-effectiveness, pharmacoeconomic analyses}, title = {How pharmacoeconomics should be applied to support decisions in lower income European countries?}, keyword = {health care resources, reimbursement, new medicines, cost-effectiveness, pharmacoeconomic analyses}, publisherplace = {Ohrid, Sjeverna Makedonija} }
@article{article, author = {Kalo, Zoltan and Vitezi\'{c}, Dinko}, year = {2014}, pages = {11-11}, keywords = {health care resources, reimbursement, new medicines, cost-effectiveness, pharmacoeconomic analyses}, title = {How pharmacoeconomics should be applied to support decisions in lower income European countries?}, keyword = {health care resources, reimbursement, new medicines, cost-effectiveness, pharmacoeconomic analyses}, publisherplace = {Ohrid, Sjeverna Makedonija} }




Contrast
Increase Font
Decrease Font
Dyslexic Font